• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

Introduction to 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone (CAS No. 1265919-34-3)

6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone, identified by its Chemical Abstracts Service (CAS) number 1265919-34-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic compound features a pyrimidinone core, which is a structural motif commonly encountered in various biologically active molecules. The presence of multiple functional groups, including hydroxyl, nitro, and sulfanyl substituents, endows this compound with unique chemical properties that make it a promising candidate for further exploration in medicinal chemistry.

The nitro group at the 5-position of the pyrimidinone ring is particularly noteworthy, as nitroaromatic compounds have long been recognized for their pharmacological potential. In recent years, there has been a surge in research focusing on the development of nitro-containing heterocycles due to their ability to modulate biological pathways through various mechanisms. For instance, nitro compounds have been investigated for their antimicrobial, antiviral, and anti-inflammatory properties. The electron-withdrawing nature of the nitro group can influence the electronic distribution within the molecule, thereby affecting its reactivity and biological activity.

The hydroxyl group at the 6-position introduces another layer of chemical diversity, enabling potential hydrogen bonding interactions with biological targets. Hydroxylated pyrimidines are known to exhibit enhanced solubility and metabolic stability, which are critical factors in drug design. Additionally, the sulfanyl group at the 2-position adds an element of sulfur chemistry, which is often associated with bioactive molecules. Sulfur-containing heterocycles are prevalent in natural products and pharmaceuticals due to their role in stabilizing molecular structures and facilitating interactions with biological macromolecules.

The propylsulfanyl moiety further enhances the complexity of this compound, contributing to its potential as a scaffold for drug discovery. Propyl derivatives are frequently explored in medicinal chemistry because they can modulate lipophilicity and metabolic clearance rates. The combination of these functional groups within a single pyrimidinone framework suggests that 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone may exhibit multifaceted biological activities.

In recent years, computational methods and high-throughput screening have accelerated the identification of novel pharmacophores. The structural features of this compound align well with emerging trends in drug design, particularly in targeting enzymes involved in inflammatory and infectious diseases. For example, studies have shown that nitro-substituted pyrimidines can interact with enzymes such as cyclooxygenases (COX) and lipoxygenases (LOX), which are key players in inflammatory pathways. The sulfanyl group may also contribute to binding affinity by forming specific interactions with cysteine residues in target proteins.

Furthermore, the pyrimidinone core itself is a privileged scaffold in medicinal chemistry, appearing in numerous approved drugs due to its ability to mimic natural nucleobases and interact with DNA or RNA-binding proteins. Modifications at positions 2, 4, and 5 provide ample opportunities for structural optimization. For instance, recent studies have demonstrated that introducing electron-withdrawing groups like nitro into pyrimidinone derivatives can enhance binding affinity to certain enzymes by increasing electrostatic interactions or π-stacking effects.

The synthesis of 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone presents an interesting challenge for synthetic chemists. The presence of multiple functional groups necessitates careful regioselective transformations to achieve the desired product without unwanted side reactions. Advanced synthetic techniques such as transition-metal-catalyzed cross-coupling reactions or organometallic chemistry may be employed to construct the pyrimidinone ring efficiently. Additionally, protecting group strategies may be required to handle the reactive hydroxyl and sulfanyl functionalities during synthesis.

Once synthesized, 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone can be subjected to rigorous biological evaluation to assess its potential therapeutic applications. In vitro assays can be used to screen for activity against a range of targets, including kinases, proteases, and transcription factors. High-resolution structural determination techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy can provide insights into how the compound interacts with its biological targets at the molecular level.

The growing interest in sulfur-containing heterocycles has also spurred research into their redox properties. Sulfanyl groups can participate in redox reactions, which may be exploited for therapeutic purposes. For example, some sulfenic acid derivatives have been shown to exhibit antitumor activity by generating reactive oxygen species (ROS) selectively within cancer cells. While 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone may not directly generate ROS, its structural features could still make it useful in redox-based therapies if further studies reveal such potential.

Another emerging area of research involves using computational modeling to predict the biological activity of novel compounds before experimental synthesis. Machine learning algorithms trained on large datasets of bioactive molecules can identify patterns that correlate structural features with biological outcomes. By applying these models to 6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone, researchers can gain insights into its likely mode of action and prioritize it for further experimental validation.

In conclusion,6-Hydroxy-5-nitro-2-[(2H7)propylsulfanyl]-4(3H)-pyrimidinone (CAS No. 1265919-34-3) represents a structurally complex and potentially bioactive molecule that warrants further investigation. Its combination of functional groups—hydroxyl,nitro, sulfanyl,and propylsulfanyl—makes it an intriguing candidate for drug discovery efforts aimed at developing treatments for inflammatory diseases or infections. As synthetic methodologies continue to advance and computational tools become more sophisticated,this compound will likely play a significant role in future medicinal chemistry research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)